Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cutaneous lymphoma].

M Beyeler1, G Burg, R Dummer

  • 1Dermatologische Klinik, Universitätsspital Zürich.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|September 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[To Prof. Dr. Dr. h.c. mult. Otto Braun-Falco: Birthday wishes and expression of appreciation from the Swiss Society for Dermatology and Venereology (SGDV)].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2012
Same author

Skin diseases in Europe. Teledermatology.

European journal of dermatology : EJD·2009
Same author

Dermatopathology.

European journal of dermatology : EJD·2009
Same author

Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2007
Same author

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

Annals of oncology : official journal of the European Society for Medical Oncology·2006
Same author

[Telemedicine in dermatology 2003: a review].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2005
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Cutaneous lymphomas, rare skin cancers, require differentiation from nodal lymphomas. While incurable, treatments focus on disease control and symptom management with new therapies emerging.

Area of Science:

  • Dermatology
  • Oncology
  • Hematology

Context:

  • Cutaneous lymphomas are rare neoplasms affecting the skin.
  • Distinguishing primary cutaneous lymphomas from secondary skin involvement of nodal lymphomas is crucial.
  • These lymphomas are categorized into B-cell and T-cell subtypes.

Purpose:

  • To provide an overview of primary cutaneous lymphomas.
  • To highlight the importance of differential diagnosis.
  • To discuss current and emerging therapeutic strategies.

Summary:

  • Primary cutaneous lymphomas, including B-cell and T-cell types, generally present with a favorable prognosis.
  • Treatment is stage-dependent and aims to control the disease and alleviate symptoms, as a cure is not achievable.

Related Experiment Videos

  • Recent advancements have introduced novel and promising therapeutic options.

    • Impact:

    • Improved understanding of cutaneous lymphoma diagnosis and management.
    • Guidance on therapeutic approaches for better patient outcomes.
    • Informed clinical decision-making regarding novel treatment modalities.